Literature DB >> 19405515

Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine.

Siyi Zhang1, Mingyao Wang, Peter W Villalta, Bruce R Lindgren, Yanbin Lao, Stephen S Hecht.   

Abstract

N'-Nitrosonornicotine (NNN) is one of the most important strong carcinogens in tobacco products and is believed to play a significant role in the induction of esophageal cancer in smokers and oral cavity cancer in snuff dippers. NNN is metabolically activated through cytochrome P450-catalyzed alpha-hydroxylation. 2'-Hydroxylation produces a reactive intermediate 4-(3-pyridyl)-4-oxobutanediazohydroxide (7), which alkylates DNA to form pyridyloxobutyl (POB)-DNA adducts. DNA pyridyloxobutylation from NNN treatment, as measured by released 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB, 8), has been observed in vitro and in vivo. In the present study, we have used liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) to analyze specific POB-DNA adducts in the nasal olfactory, nasal respiratory, and oral mucosa of F344 rats treated chronically with (R)-NNN or (S)-NNN in the drinking water (10 ppm, 1-20 weeks). Adduct levels in the nasal respiratory mucosa exceeded those in the nasal olfactory and oral mucosa. (R)-NNN treatment generated 2-4 times more adducts in the nasal olfactory and respiratory mucosa than did (S)-NNN at most time points. O(2)-[4-(3-Pyridyl)-4-oxobut-1-yl]thymidine (O(2)-POB-dThd, 11) predominated in the nasal olfactory and respiratory mucosa, followed by 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine (7-POB-Gua, 14). Levels of O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]cytosine (O(2)-POB-Cyt, 13) and O(6)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine (O(6)-POB-dGuo, 12) were significantly lower. In the oral mucosa, the opposite stereoselectivity was observed, with (S)-NNN treatment producing 3-5 times more POB-DNA adducts than did (R)-NNN. O(2)-POB-dThd and 7-POB-dGuo were the two major adducts, and their levels were similar. Overall, POB-DNA adduct formation in the nasal olfactory and nasal respiratory mucosa was similar to that previously observed in the lung, whereas in the oral mucosa, the trend resembled that in the esophagus. These results indicate that different mechanisms are involved in NNN metabolism and tumorigenesis in rat nasal and oral tissues. NNN enters the nasal mucosa through the circulation, and tissue-specific metabolism is important, while in the oral mucosa, direct exposure and local activation both play significant roles. Our results also support the potential importance of NNN as an oral carcinogen in people who use smokeless tobacco products.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405515      PMCID: PMC2743010          DOI: 10.1021/tx900040j

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  35 in total

1.  Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens.

Authors:  Mingyao Wang; Guang Cheng; Shana J Sturla; Yongli Shi; Edward J McIntee; Peter W Villalta; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2003-05       Impact factor: 3.739

2.  Metabolism of N'-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats.

Authors:  E J McIntee; S S Hecht
Journal:  Chem Res Toxicol       Date:  2000-03       Impact factor: 3.739

3.  Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine.

Authors:  Yanbin Lao; Nanxiong Yu; Fekadu Kassie; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

4.  Enantiomeric composition of N'-nitrosonornicotine and N'-nitrosoanatabine in tobacco.

Authors:  S G Carmella; E J McIntee; M Chen; S S Hecht
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

5.  Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N'-nitrosonornicotine enantiomers.

Authors:  S E Murphy; I S Isaac; X Ding; E J McIntee
Journal:  Drug Metab Dispos       Date:  2000-11       Impact factor: 3.922

6.  Identification of adducts formed in the reactions of 5'-acetoxy-N'-nitrosonornicotine with deoxyadenosine, thymidine, and DNA.

Authors:  Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

7.  Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA.

Authors:  Stephen S Hecht; Peter W Villalta; Shana J Sturla; Guang Cheng; Nanxiong Yu; Pramod Upadhyaya; Mingyao Wang
Journal:  Chem Res Toxicol       Date:  2004-05       Impact factor: 3.739

8.  Metabolism of N'-nitrosonornicotine by cultured rat esophagus.

Authors:  S S Hecht; B Reiss; D Lin; G M Williams
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

9.  Formation of tissue-bound N'-nitrosonornicotine metabolites by the target tissues of Sprague-Dawley and Fisher rats.

Authors:  E B Brittebo; H Tjälve
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

10.  Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  S S Hecht; C B Chen; T Ohmori; D Hoffmann
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

View more
  20 in total

1.  Transcriptome profiling in oral cavity and esophagus tissues from (S)-N'-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis.

Authors:  Ali Khammanivong; Arunkumar Anandharaj; Xuemin Qian; Jung Min Song; Pramod Upadhyaya; Silvia Balbo; Dipankar Bandyopadhyay; Erin B Dickerson; Stephen S Hecht; Fekadu Kassie
Journal:  Mol Carcinog       Date:  2016-01-19       Impact factor: 4.784

2.  Quantitation of pyridyloxobutyl-DNA adducts in tissues of rats treated chronically with (R)- or (S)-N'-nitrosonornicotine (NNN) in a carcinogenicity study.

Authors:  Lijiao Zhao; Silvia Balbo; Mingyao Wang; Pramod Upadhyaya; Samir S Khariwala; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-09-18       Impact factor: 3.739

3.  Mass Spectrometric Quantitation of Pyridyloxobutyl DNA Phosphate Adducts in Rats Chronically Treated with N'-Nitrosonornicotine.

Authors:  Yupeng Li; Bin Ma; Qing Cao; Silvia Balbo; Lijiao Zhao; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2019-02-26       Impact factor: 3.739

Review 4.  Evolution of research on the DNA adduct chemistry of N-nitrosopyrrolidine and related aldehydes.

Authors:  Stephen S Hecht; Pramod Upadhyaya; Mingyao Wang
Journal:  Chem Res Toxicol       Date:  2011-04-21       Impact factor: 3.739

5.  Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Irina Stepanov; John Muzic; Chap T Le; Erin Sebero; Peter Villalta; Bin Ma; Joni Jensen; Dorothy Hatsukami; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-01-10       Impact factor: 3.739

6.  Mass Spectrometric Quantitation of Apurinic/Apyrimidinic Sites in Tissue DNA of Rats Exposed to Tobacco-Specific Nitrosamines and in Lung and Leukocyte DNA of Cigarette Smokers and Nonsmokers.

Authors:  Jiehong Guo; Haoqing Chen; Pramod Upadhyaya; Yingchun Zhao; Robert J Turesky; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2020-09-09       Impact factor: 3.739

7.  Formation, repair, and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines.

Authors:  Lisa A Peterson
Journal:  J Nucleic Acids       Date:  2010-09-05

8.  Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products.

Authors:  Irina Stepanov; Katrina Yershova; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2012-12-03       Impact factor: 4.244

9.  DNA Adduct Formation from Metabolic 5'-Hydroxylation of the Tobacco-Specific Carcinogen N'-Nitrosonornicotine in Human Enzyme Systems and in Rats.

Authors:  Adam T Zarth; Pramod Upadhyaya; Jing Yang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2016-02-09       Impact factor: 3.739

10.  Clinical and biochemical studies support smokeless tobacco's carcinogenic potential in the human oral cavity.

Authors:  Susan R Mallery; Meng Tong; Gregory C Michaels; Amber R Kiyani; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.